Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel

BACKGROUND: Immunotherapy (IO) has been associated with improved outcomes in patients with locally advanced Merkel cell carcinoma (laMCC) and metastatic Merkel cell carcinoma (mMCC). The primary objective of SPEAR‐Merkel was to explore treatment patterns, clinical outcomes, and health care resource...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhanegaonkar, Abhijeet, Liu, Frank X., Boyd, Marley, Fulcher, Nicole, Kim, Ruth, Krulewicz, Stan, Smith, Jodi, Cowey, C. Lance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Melanoma and Cutaneous Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417847/
https://www.ncbi.nlm.nih.gov/pubmed/34101298
http://dx.doi.org/10.1002/onco.13845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417847/
https://www.ncbi.nlm.nih.gov/pubmed/34101298
http://dx.doi.org/10.1002/onco.13845

Ejemplares similares